WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Veracyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 10:41 am Sale | 2024-09-30 | 13G | Veracyte, Inc. VCYT | WELLINGTON MANAGEMENT GROUP LLP | 4,232,844 5.510% | -2,835,591 (-40.12%) | Filing |
| 2024-02-08 10:18 am Sale | 2023-12-29 | 13G | Veracyte, Inc. VCYT | WELLINGTON MANAGEMENT GROUP LLP | 7,068,435 9.680% | -180,454 (-2.49%) | Filing |
| 2023-06-09 10:14 am Purchase | 2023-05-31 | 13G | Veracyte, Inc. VCYT | WELLINGTON MANAGEMENT GROUP LLP | 7,248,889 10.010% | 612,346 (+9.23%) | Filing |
| 2023-02-06 2:58 pm Purchase | 2022-12-30 | 13G | Veracyte, Inc. VCYT | WELLINGTON MANAGEMENT GROUP LLP | 6,636,543 9.250% | 1,557,716 (+30.67%) | Filing |
| 2022-02-04 09:24 am Purchase | 2021-12-31 | 13G | Veracyte, Inc. VCYT | WELLINGTON MANAGEMENT GROUP LLP | 5,078,827 7.150% | 5,078,827 (New Position) | Filing |